{
  "meta": {
    "title": "86_Pathology_Neet_2022",
    "url": "https://brainandscalpel.vercel.app/86-pathology-neet-2022-5c0e9a71.html",
    "scrapedAt": "2025-11-30T12:58:30.680Z"
  },
  "questions": [
    {
      "text": "Choose the correct statement regarding the telomerase theory of aging.",
      "choices": [
        {
          "id": 1,
          "text": "Telomere stability is associated with aging"
        },
        {
          "id": 2,
          "text": "Abnormal telomerase activation is associated with aging"
        },
        {
          "id": 3,
          "text": "Decreased telomere length is associated with aging"
        },
        {
          "id": 4,
          "text": "Increased telomere length is associated with aging"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>A<strong> decreased telomere length</strong> is associated with <strong>aging.<br /></strong></p>\n<div class=\"page\" title=\"Page 79\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Telomeres</strong> are short <strong>TG-rich repeated</strong> sequences of <strong>DNA</strong> present at the ends of linear eukaryotic chromosomes. Telomeres do not code for any proteins. They are important for ensuring the <strong>complete replication</strong> of chromosome ends and for <strong>protecting</strong> the <strong>ends</strong> from <strong>fusion</strong> and <strong>degradation.</strong></p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Normally</strong>, with every cell division, there is some <strong>shortening</strong> of <strong>telomeres</strong>&nbsp;at the ends of chromosomes. Once the telomeres are shortened beyond a certain point, it may cause cell-cycle arrest or&nbsp;<strong>apoptosis</strong>. This is called <strong>replicative senescence</strong>.</p>\n<p><strong>Telomerase </strong>is the enzyme that <strong>prevents</strong> the <strong>shortening</strong> of <strong>telomeres</strong>. It is a specialized <strong>RNA-protein complex</strong> that <strong>uses</strong> its own <strong>RNA</strong> as a <strong>template</strong> for adding nucleotides to the ends of chromosomes.</p>\n<p>This enzyme is usually present in germ cells but is&nbsp;<strong>absent </strong>in most <strong>somatic cells. </strong>Therefore most of the <strong>somatic cells age</strong>, their telomeres become shorter and they exit the cell cycle, resulting in an inability to generate new cells to replace damaged cells.&nbsp;<strong>Abnormal telomerase reactivation</strong> in somatic cells leads to <strong>evasion</strong> of <strong>senescence</strong> and apoptosis. It enables the cells to divide several times than usual.</p>\n<p>In<strong> stem cells </strong>and<strong> cancer cells</strong>, telomerase is usually reactivated and <strong>telomere</strong> length is <strong>stabilized,</strong> allowing the <strong>cells</strong> to <strong>proliferate indefinitely.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5343",
      "difficulty": "easy"
    },
    {
      "text": "A child presents with recurrent chest infections and abdominal pain. There is a history of 1 blood transfusion in the past. On examination, he had icterus and mild splenomegaly. Electrophoresis shows increased HbA2, HbF, and S spike. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Beta thalassemia"
        },
        {
          "id": 2,
          "text": "HbC disease"
        },
        {
          "id": 3,
          "text": "Sickle cell disease"
        },
        {
          "id": 4,
          "text": "Acute coronary disease"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario with electrophoresis showing increased HbA2, HbF, and S spike is suggestive of <strong>sickle cell disease</strong>. </p>\n<p>Sickle cell anemia is an <strong>autosomal recessive </strong>disorder that occurs due to the <strong>point mutation</strong> in the β-globin gene which results in the replacement of glutamate residue with valine. This causes the production of <strong>sickle-shaped red blood cells</strong> due to the polymerization of <strong>deoxygenated</strong> <strong>hemoglobin (HbS).</strong></p>\n<p>Factors that predispose to sickling are infection, dehydration, and acidosis.</p>\n<p>The <strong>clinical features</strong> of sickle cell disease are due to the tendency of <strong>HbS molecules</strong> to <strong>stack</strong> into <strong>polymers</strong> when <strong>deoxygenated.</strong> The features are:</p>\n<ul>\n<li>Moderately severe hemolytic anemia with jaundice.</li>\n<li><strong>Painful bone crisis-</strong> hand-foot syndrome or dactylitis of the bones of hands and feet.</li>\n<li><strong>Acute chest syndrome</strong> typically presents with fever, cough, chest pain, and <strong>pulmonary infiltrates</strong>.</li>\n<li>Hyposthenuria- inability to concentrate urine.</li>\n<li><strong>Aplastic crisis</strong> stems from the infection of red cell progenitors by <em>parvovirus B19</em>, which causes a transient cessation of erythropoiesis and a sudden worsening of the anemia.</li>\n<li>Spleen\n<ul>\n<li>In children- <strong>splenic sequestration</strong> crises occur which results in <strong>splenomegaly</strong> due to red pulp congestion.</li>\n<li>Adolescence or early adulthood- <strong>autosplenectomy</strong> occurs due to splenic infarction, fibrosis, and progressive shrinkage.</li>\n<li>Increased susceptibility to infection with encapsulated organisms like pneumococcal, meningococcal, and <em>Haemophilus influenza</em> septicemia, but can be reduced by vaccination and prophylactic antibiotics.</li>\n</ul>\n</li>\n<li>Other clinical features- priapism, leg ulcers, <strong>stroke</strong>, retinopathy, pigment gallstones, and growth retardation.</li>\n</ul>\n<p>The diagnosis is suggested by the clinical findings, the presence of irreversibly sickled red cells on peripheral smear, and hemoglobin electrophoresis showing<strong> increased levels of HbA2, HbF,</strong> and <strong>S spike</strong>. The changes in the skull resemble a <strong>crewcut</strong> in radiographic studies as a result of compensatory erythroid hyperplasia.</p>\n<p>The image given below shows the sickling of RBCs in sickle cell disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eb3825393aff4017bd812141e8d3ec77x1280x960.JPEG\" alt=\"Explanation Image\"><p>The image given below shows Howell-Jolly bodies seen in asplenia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2d6c82c1ef6a49469bd89681e8a61d7dx610x600.PNG\" alt=\"Explanation Image\"><p>Note: The sickle cell trait protects against <strong>falciparum malaria</strong> in certain African populations.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Beta-thalassemia</strong> is an autosomal codominant disorder, caused by mutations in alpha or beta globin that reduce hemoglobin synthesis. Peripheral smear shows <strong>microcytic, hypochromic</strong> cells with anisocytosis, poikilocytosis, <strong>target cells,</strong> and basophilic stippling. Hemoglobin electrophoresis shows increased <strong>HbF</strong> and <strong>HbA2</strong>.</p>\n<p>Option B: <strong>HbC disease</strong> is caused by mutation in the beta-globin chain in which <strong>glutamate is replaced by lysine</strong> in the sixth position of the beta-globin chain. Patients usually present with very mild anemia and microcytosis. Peripheral smear shows hexagonal HbC crystals. Hemoglobin electrophoresis shows increased <strong>HbC</strong> levels.</p>\n<p>Option D: <strong>Acute coronary syndrome</strong> is very rare in children and may be associated with <strong>Kawasaki disease</strong>. Children with Kawasaki disease present with fever, conjunctival ingestion, <strong>strawberry tongue</strong>, polymorphous rash, cervical lymphadenopathy, and hand and foot changes. They are treated with <strong>intravenous immunoglobulin</strong> and <strong>aspirin</strong>.</p><p><strong>World Sickle Cell Day</strong> emphasises the importance of early detection and intervention to prevent complications and improve outcomes for individuals with SCD. It encourages screening programs, newborn screening initiatives, and genetic counselling to identify carriers and provide appropriate support and management</p><hr><h3>Related Pearl: Structural Alterations of the β -Globin Gene</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Alteration</p>\n</td>\n<td>\n<p>Function affected</p>\n</td>\n<td>\n<p>Disease</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"4\">\n<p>Point Mutation</p>\n</td>\n<td>\n<p>Protein folding</p>\n</td>\n<td>\n<p>Sickle cell disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Transcriptional control</p>\n</td>\n<td>\n<p>&beta;-Thalassemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Frameshift &amp; nonsense mutations</p>\n</td>\n<td>\n<p>&beta;-Thalassemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>RNA processing</p>\n</td>\n<td>\n<p>&beta;-Thalassemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Deletion</p>\n</td>\n<td>\n<p>mRNA production</p>\n</td>\n<td>\n<p>&beta;<sup>0</sup>-Thalassemia</p>\n<p>Hemoglobin Lepore</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rearrangement</p>\n</td>\n<td>\n<p>mRNA production</p>\n</td>\n<td>\n<p>&beta;-Thalassemia type III</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Inheritance pattern of important diseases</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal dominant</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal recessive</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>HEAV</strong>y<strong> DOMINANT</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>ABC DEF GHI</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>ereditary spherocytosis, <strong>H</strong>ypercholesterolemia,&nbsp;<strong>H</strong>ypertrophic obstructive cardiomyopathy,&nbsp; <strong>H</strong>untington&rsquo;s disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>taxia-telangiectasia,&nbsp;<strong>A</strong>lbinism, <strong>A</strong>lkaptonuria,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>A</strong>utosomal-recessive polycystic kidney disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>hler-Danlos syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>B</strong>: <strong>B</strong>lood disorders like&nbsp;<strong>b</strong>eta-thalassemia and sickle-cell anemia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>chondroplasia</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>C</strong>: <strong>C</strong>ystic fibrosis,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>C</strong>ongenital adrenal hyperplasia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>V</strong>: <strong>V</strong>on Willebrand disease, Von Hippel Lindau disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: Sensorineural <strong>d</strong>eafness</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: <strong>D</strong>ystrophia myotonica</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>mphysema&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span>(alpha1- antitrypsin deficiency)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>O</strong>: <strong>O</strong>steogenesis imperfecta,&nbsp;<strong>O</strong>tosclerosis (variable)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>F</strong>: <strong>F</strong>riedrich ataxia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>M</strong>: <strong>M</strong>arfans syndrome, Multiple endocrine neoplasias (MEN)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>G</strong>: <strong>G</strong>aucher&rsquo;s disease, <strong>G</strong>alactosemia, glycogen storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>ntermittent porphyria</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>omocystinuria, <strong>H</strong>emochromatosis</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>N</strong>: <strong>N</strong>eurofibromatosis 1 and 2</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>nborn errors of metabolism- Phenylketonuria, lysosomal storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>A</strong>: <strong>A</strong>utosomal-dominant polycystic kidney disease</span></td>\n<td class=\"td1\" valign=\"top\">Other conditions: Wilson's disease, sickle cell anemia, thalassemias, spinal muscular atrophy, Kartagener syndrome,&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>N</strong>: <strong>N</strong>oonan's syndrome</span></td>\n<td class=\"td1\" valign=\"top\">Mucopolysaccharidoses (except Hunter syndrome)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>T</strong>: <strong>T</strong>uberous sclerosis</span></td>\n<td class=\"td1\" valign=\"top\">Sphingolipidoses (except Fabry disease)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span>Other conditions:<strong>&nbsp;</strong>Familial adenomatous polyposis, Hereditary hemorrhagic telangiectasia, Li-Fraumeni syndrome, Pseudohypoparathyroidism</span></td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked recessive</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked dominant</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Lady Hardinge College Girls Don&rsquo;t Care About Foolish Words</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Red Rose </strong>for<strong> All Children</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>L</strong>ady) <strong>L</strong>esch&ndash;Nyhan syndrome,&nbsp;<strong>L</strong>owe syndrome</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ed) <strong>R</strong>ett&rsquo;s syndrome</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>H</strong>ardinge) <strong>H</strong>unter's syndrome, <strong>H</strong>emophilia A and B</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ose) <strong>R</strong>ickets</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>ollege) <strong>C</strong>hronic granulomatous disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div><span>(<strong>A</strong>ll) <strong>A</strong>lport syndrome&nbsp;(common inheritance pattern)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>G</strong>irls) <strong>G</strong>-6-PD deficiency</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>hildren) Type X <strong>C</strong>harcot&ndash;Marie&ndash;Tooth disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>D</strong>on&rsquo;t) <strong>D</strong>uchenne muscular dystrophy, <strong>D</strong>iabetes insipidus</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>are) <strong>C</strong>olor blindness</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>A</strong>bout) <strong>A</strong>gammaglobulinemia,&nbsp;<strong>A</strong>lport syndrome, Ocular&nbsp;<strong>a</strong>lbinism</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(Foolish)&nbsp;<strong>F</strong>abry disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>W</strong>ords) <strong>W</strong>iskott&ndash;Aldrich syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>Other conditions: Menke's disease,&nbsp;</span>Ornithine transcarbamylase deficiency</div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span>&nbsp;</span></p><hr><h3>Related Pearl: Pathological Named Bodies</h3><table>\n<tbody>\n<tr>\n<td><strong>Bodies</strong></td>\n<td><strong>Found in</strong></td>\n</tr>\n<tr>\n<td>Asteroid bodies</td>\n<td>Sarcoidosis, Sporotrichosis</td>\n</tr>\n<tr>\n<td>\n<p>Halberstaedter&ndash;Prowazek bodies</p>\n</td>\n<td>Trachoma&nbsp;</td>\n</tr>\n<tr>\n<td>Miyagawa bodies</td>\n<td>Lymphogranuloma venereum&nbsp;</td>\n</tr>\n<tr>\n<td>Levinthal&ndash;Cole&ndash;Lillie bodies</td>\n<td>Psittacosis</td>\n</tr>\n<tr>\n<td>Leishman&ndash;Donovan bodies</td>\n<td>Kala-azar&nbsp;</td>\n</tr>\n<tr>\n<td>Negri bodies</td>\n<td>Rabies</td>\n</tr>\n<tr>\n<td>Guarnieri bodies</td>\n<td>Vaccinia</td>\n</tr>\n<tr>\n<td>Bollinger bodies</td>\n<td>Fowl pox</td>\n</tr>\n<tr>\n<td>Henderson&ndash;Paterson bodies</td>\n<td>Molluscum contagiosum&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-A bodies</td>\n<td>Yellow fever, Herpes virus infection&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-B bodies</td>\n<td>Adenovirus, poliovirus</td>\n</tr>\n<tr>\n<td>Rusell bodies</td>\n<td>Multiple myeloma&nbsp;</td>\n</tr>\n<tr>\n<td>Aschoff bodies</td>\n<td>Rheumatic fever&nbsp;</td>\n</tr>\n<tr>\n<td>Call&ndash;Exner bodies</td>\n<td>Granulosa cell tumor of the&nbsp;ovary&nbsp;</td>\n</tr>\n<tr>\n<td>Civatte (colloid) bodies</td>\n<td>Lichen planus&nbsp;</td>\n</tr>\n<tr>\n<td>Michaelis&ndash;Gutmann bodies</td>\n<td>Malakoplakia&nbsp;</td>\n</tr>\n<tr>\n<td>Lewy bodies</td>\n<td>Parkinson's disease&nbsp;</td>\n</tr>\n<tr>\n<td>Pappenheimer bodies</td>\n<td>Non-heme iron pigments in siderocytes&nbsp;</td>\n</tr>\n<tr>\n<td>Howell&ndash;Jolly bodies</td>\n<td>Splenectomy, Megaloblastic Anemia, Hemolytic anemia&nbsp;</td>\n</tr>\n<tr>\n<td>Heinz bodies</td>\n<td>G-6-PD deficiency&nbsp;</td>\n</tr>\n<tr>\n<td>Gamna&ndash;Gandy bodies</td>\n<td>Congestive splenomegaly&nbsp;</td>\n</tr>\n<tr>\n<td>Mallory bodies</td>\n<td>Hyaline inclusions in hepatocytes seen in alcoholic cirrhosis, Indian childhood cirrhosis</td>\n</tr>\n<tr>\n<td>Councilman bodies</td>\n<td>Hepatocytes undergoing apoptosis,&nbsp;seen mainly in acute viral hepatitis.</td>\n</tr>\n<tr>\n<td>Psammoma bodies</td>\n<td>Dystrophic calcification in meningioma, papillary serous cystadenoma of ovary &amp; papillary carcinoma of thyroid, papillary type of renal cell carcinoma.</td>\n</tr>\n<tr>\n<td>Donovan bodies</td>\n<td>Granuloma inguinale&nbsp;</td>\n</tr>\n<tr>\n<td>Nissl's bodies</td>\n<td>Cytoplasmic inclusions in neurons&nbsp;</td>\n</tr>\n<tr>\n<td>Mooser bodies</td>\n<td>Typhus fever</td>\n</tr>\n<tr>\n<td>Creola bodies</td>\n<td>Asthma&nbsp;</td>\n</tr>\n<tr>\n<td>Verocay bodies</td>\n<td>Schwannoma&nbsp;</td>\n</tr>\n<tr>\n<td>Schiller&ndash;Duval bodies</td>\n<td>Endodermal sinus tumor&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Hirano bodies</p>\n</td>\n<td>&nbsp;Alzheimer&rsquo;s disease</td>\n</tr>\n<tr>\n<td>\n<p>Ferruginous bodies</p>\n</td>\n<td>Asbestosis&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5279",
      "difficulty": "medium"
    },
    {
      "text": "Why do neoplastic cells utilize Warburg metabolism?",
      "choices": [
        {
          "id": 1,
          "text": "It decreases glucose utilisation by neoplastic cells"
        },
        {
          "id": 2,
          "text": "It forms metabolic intermediates which are needed for cell growth and multiplication"
        },
        {
          "id": 3,
          "text": "It provides more energy in the form of increased ATP production"
        },
        {
          "id": 4,
          "text": "It prevents apoptosis and makes the cancer cells immortal"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p><span class=\"ILfuVd\" lang=\"en\"><span class=\"hgKElc\">Neoplastic cells utilize <strong>Warburg</strong> metabolism for the<strong> generation</strong> of<strong> metabolic intermediates,</strong> which are<strong> needed</strong> for<strong> cell growth </strong>and<strong> multiplication</strong>.</span></span></p>\n<p><span class=\"ILfuVd\" lang=\"en\"><span class=\"hgKElc\">The Warburg Effect is a phenomenon in which there is an increase in the rate of <strong>glucose</strong> uptake and <strong>conversion</strong> into<strong> lactate</strong>(fermentation), even in the presence of <strong>oxygen</strong>. </span></span>Cancer cells derive energy mainly from glycolysis.<strong>&nbsp;</strong></p>\n<p>Cancer cells utilize glycolysis (2 ATP) over mitochondrial oxidative phosphorylation (36 ATP) for glucose metabolism, even though the latter produces more ATP. It is because&nbsp;pure<strong> oxidative phosphorylation</strong>&nbsp;produces abundant ATP, but also burns glucose to CO<sub>2&nbsp;</sub>and H<sub>2</sub>O, leaving <strong>no carbon moieties</strong> suitable for use as building blocks for lipids or proteins.</p>\n<p>For this reason,&nbsp;<strong>rapidly growing cells,</strong> by undergoing glycolysis, produce carbon moieties that are needed for growth and cellular maintenance.</p>\n<p>The image given below shows the comparison of glucose metabolism in normal cells versus cancer cells.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7e0b29805eec44e38435049d40c7642cx773x293.JPEG\" alt=\"Explanation Image\"><p>As a result of decreased ATP production, the main metabolic function of mitochondria in growing cells is not to generate ATP, but to carry<br />out reactions that generate cellular building blocks. For example, lipid biosynthesis.</p>\n<p>Warburg effect is produced by <strong>growth factor receptors</strong> downstream signalling pathways. These include <strong>receptor tyrosine kinase/PI3K/AKT </strong>and <strong>MYC.</strong></p>\n<p>Clinically, cancer cells exhibiting the Warburg effect show a property of <strong>glucose hunger</strong>. This is used to visualize them via <strong>positron emission tomography (PET)</strong> scanning.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5329",
      "difficulty": "medium"
    },
    {
      "text": "An elderly patient presents with anemia and hemoglobinuria. Investigations reveal increased lactate dehydrogenase (LDH). The peripheral smear image is given below. Which of the following physical examination findings can support the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Splenomegaly"
        },
        {
          "id": 2,
          "text": "Frontal bossing"
        },
        {
          "id": 3,
          "text": "Mechanical second heart sound"
        },
        {
          "id": 4,
          "text": "Goitre"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above scenario with&nbsp;<strong>anemia, increased LDH,</strong> and <strong>hemoglobinuria</strong> along with peripheral smear showing <strong>schistocytes</strong> are suggestive of&nbsp;<strong>macroangiopathic hemolytic anemia</strong>&nbsp;(MAHA). The presence of a <strong>mechanical second heart sound</strong>&nbsp;can support the diagnosis.&nbsp;</p>\n<p><strong>Macroangiopathic hemolytic anemia </strong>is a type of hemolytic anemia that results from trauma to red cells by a<strong>rtificial</strong> mechanical cardiac <strong>valves</strong> that produce <strong>turbulent</strong> blood <strong>flow</strong> and pressure gradients that cause hemolysis from shear forces. This traumatic damage leads to <strong>intravascular hemolysis</strong> and the appearance of red cell fragments (schistocytes), burr cells, helmet cells, and triangle cells in blood smears.</p>\n<p>The given below peripheral smear shows schistocytes and helmet cells.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d4b44cb582324197bc21853970153653x1280x1147.JPEG\" alt=\"Explanation Image\"><p>Laboratory findings in hemolytic anemia resulting from trauma to red cells:</p>\n<ul>\n<li><strong>Hemoglobin- decreased</strong></li>\n<li>Reticulocytes- increased</li>\n<li>Platelets- normal</li>\n<li>Unconjugated bilirubin- increased</li>\n<li><strong>Lactate dehydrogenase- increased</strong></li>\n<li>Haptoglobin- decreased</li>\n<li><strong>Hemoglobinuria</strong> due to intravascular hemolysis</li>\n</ul>\n<p><strong>Treatment</strong> is <strong>conservative.</strong> But, if more than mild anemia develops, reintervention to correct regurgitation may be required.</p>\n<p>Option A: <strong>Splenomegaly</strong> is seen in various disorders of white and red cells. But splenomegaly in intravascular hemolysis is less likely.</p>\n<p>Option B: <strong>Frontal bossing</strong> is seen in <strong>thalassemia</strong> due to expansion of hematopoietically active marrow. An X-ray of the skull shows a 'crewcut' appearance. Peripheral smear in thalassemia shows microcytic hypochromic cells with anisocytosis, poikilocytosis, and <strong>target cells</strong>.</p>\n<p>Option D: <strong>Goiter</strong> is usually associated with <strong>iron deficiency anemia</strong>. A peripheral smear shows microcytic hypochromic cells.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/489eff66c28845e7bfc170c067dd22c1.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5308",
      "difficulty": "hard"
    },
    {
      "text": "All of the following statements are true regarding neutrophil extracellular trapping (NET) except that",
      "choices": [
        {
          "id": 1,
          "text": "It is detected in blood during sepsis."
        },
        {
          "id": 2,
          "text": "It is produced in response to bacterial infection."
        },
        {
          "id": 3,
          "text": "Mitochondrial DNA is seen."
        },
        {
          "id": 4,
          "text": "It is chromatin with antibacterial enzymes."
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p><strong>Mitochondrial DNA </strong>is not seen in<strong> neutrophil extracellular traps </strong>(NET).</p>\n<p>Neutrophilic extracellular traps are <strong>networks of extracellular fibers</strong> that provide a high concentration of antimicrobial substances at the site of infection and <strong>prevent the spread of the microbes </strong>by trapping them in the fibrils.</p>\n<p>Neutrophilic extracellular traps (NET) are the meshwork of <strong>nuclear chromatin of neutrophils</strong>. The loss of nuclei leads to the death of the neutrophils. They concentrate&nbsp;<strong>antimicrobial</strong> peptides and <strong>enzymes</strong> to fight against <strong>bacteria</strong> and<strong> fungus&nbsp;</strong>(not viruses). They are detected in the blood during<strong> sepsis.</strong> They are produced by neutrophils in response to:</p>\n<ul>\n<li><strong>Infectious pathogens:</strong>&nbsp;mainly bacteria and fungi</li>\n<li><strong>Inflammatory mediators:</strong>&nbsp;chemokines, cytokines (mainly interferons), complement proteins, and reactive oxygen species (ROS)</li>\n</ul>\n<p>Note: The <strong>nuclear chromatin</strong> in the NETs, which includes histones and associated DNA, has been postulated to be a source of nuclear antigens in systemic <strong>autoimmune diseases</strong>, particularly systemic lupus erythematosus (SLE).</p>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5264",
      "difficulty": "medium"
    },
    {
      "text": "A patient underwent cystoscopy, which showed multiple yellow-white plaques in the trigone of the bladder. The histopathology image is given below. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Interstitial cystitis"
        },
        {
          "id": 2,
          "text": "Malakoplakia"
        },
        {
          "id": 3,
          "text": "Polypoid cystitis"
        },
        {
          "id": 4,
          "text": "Acute cystitis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The cystoscopy findings of multiple <strong>yellow</strong>-<strong>white plaques </strong>in the trigone of the bladder and histopathology image showing <strong>Michaelis–Gutmann bodies</strong> are consistent with the diagnosis of <strong>malakoplakia.</strong></p>\n<p>Malakoplakia is a rare <strong>inflammatory</strong> reaction seen in chronic cystitis. It is caused due to acquired <strong>defects in phagocyte function, </strong>chronic bacterial infection by <em><strong>Escherichia coli</strong></em> or <em><strong>Proteus </strong></em>species, and immunosuppression (renal transplant patients).</p>\n<p>The term malakoplakia means <strong>soft plaques</strong>. Grossly, malakoplakia appears as soft, yellow, slightly raised <strong>mucosal plaques. </strong></p>\n<p>Microscopically, they are composed of <strong>large, foamy macrophages</strong> mixed with occasional multinucleate giant cells and lymphocytes. The <strong>macrophages</strong> in malakoplakia have abundant granular cytoplasm due to <strong>phagosomes</strong> stuffed with undigested bacterial products and intracellular deposition of calcium and iron within enlarged lysosomes form laminated basophilic concretions. These are known as <strong>Michaelis–Gutmann bodies</strong>, pathognomonic of malakoplakia (shown below).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/47a3d60857e047babd8641b36e8e9fc0x1279x1079.JPEG\" alt=\"Explanation Image\"><p> </p>\n<p>The image given below shows the <strong>Von Kossa stain</strong> demonstrating calcium and iron-containing Michaelis-Gutman bodies (MG bodies) in malakoplakia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/928b9801bda54ff68dd1c78ea5d00b86x1199x816.JPEG\" alt=\"Explanation Image\"><p> </p>\n<p>Note: Xanthogranulomatous cystitis is morphologically and probably pathogenetically similar to malakoplakia, but it lacks Michaelis–Gutmann bodies.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Interstitial cystitis, </strong>also known as chronic pelvic pain syndrome, is a disorder of the urinary bladder that presents with urinary tract symptoms of <strong>more than six weeks</strong> duration of <strong>unknown etiology</strong>. Grossly, it is associated with chronic mucosal ulcers called <strong>Hunner's ulcers</strong>. Microscopically, there is a non-specific increase in <strong>mast cells</strong> in the submucosa. Biopsy should be done in all cases to <strong>rule out carcinoma in situ.</strong></p>\n<p>The cystoscopy image shows Hunner's ulcer, seen in interstitial cystitis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f0d49e2ceccc422382785f7837169051x405x421.JPEG\" alt=\"Explanation Image\"><p> </p>\n<p>Option C: <strong>Polypoid cystitis</strong> is an inflammatory lesion resulting from irritation of the bladder mucosa, most commonly due to <strong>indwelling catheters</strong>. The urothelium is thrown into broad bulbous polypoid projections due to marked submucosal edema. They must be differentiated from <strong>papillary urothelial carcinoma.</strong></p>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>The given image below shows polypoid cystitis showing broad polypoid growth, prominent blood vessels, and metaplastic urothelium in H&amp;E stain.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9fd4cd8271a047bb92c61bd96226dc01x640x427.JPEG\" alt=\"Explanation Image\"><p> </p>\n<p>Option D: <strong>Acute cystitis</strong> is characterized by an inflammation of the urinary bladder following infection, most commonly by <strong><em>Escherichia coli</em></strong>, <em>Proteus, Klebsiella, </em>and<em> Enterobacter</em>. It is more commonly seen in women due to <strong>the short urethra</strong>. Microscopically, there is hyperemia and neutrophilic infiltration of the mucosa.</p><hr><h3>Related Pearl: Types of Cystitis</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of cystitis</strong></td>\n<td><strong>Etiology</strong></td>\n<td><strong>Characteristic features</strong></td>\n</tr>\n<tr>\n<td>Interstitial cystitis</td>\n<td>Idiopathic</td>\n<td>Hunner's ulcer</td>\n</tr>\n<tr>\n<td>Polypoid cystitis</td>\n<td>Catheterization of bladder</td>\n<td>Mimics malignancy</td>\n</tr>\n<tr>\n<td>Malakoplakia</td>\n<td>Defective phagocytosis</td>\n<td>Michaelis&ndash; Gutmann bodies</td>\n</tr>\n<tr>\n<td>Eosinophilic cystitis</td>\n<td>Systemic allergic disorders</td>\n<td>Submucosal eosinophils</td>\n</tr>\n<tr>\n<td>Emphysematous cystitis</td>\n<td><em>Clostridium perfringens</em></td>\n<td>Associated with Diabetes</td>\n</tr>\n<tr>\n<td>Follicular cystitis</td>\n<td>Prolonged urinary retention, intravesicular chemotherapy or BCG</td>\n<td>Lymphoid follicles within bladder mucosa</td>\n</tr>\n<tr>\n<td>Hemorrhagic cystitis</td>\n<td>\n<p>Cyclo-phosphamide, BK virus, Adenovirus</p>\n</td>\n<td>Prophylactic administration of mesna reduces the incidence</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Pathological Named Bodies</h3><table>\n<tbody>\n<tr>\n<td><strong>Bodies</strong></td>\n<td><strong>Found in</strong></td>\n</tr>\n<tr>\n<td>Asteroid bodies</td>\n<td>Sarcoidosis, Sporotrichosis</td>\n</tr>\n<tr>\n<td>\n<p>Halberstaedter&ndash;Prowazek bodies</p>\n</td>\n<td>Trachoma&nbsp;</td>\n</tr>\n<tr>\n<td>Miyagawa bodies</td>\n<td>Lymphogranuloma venereum&nbsp;</td>\n</tr>\n<tr>\n<td>Levinthal&ndash;Cole&ndash;Lillie bodies</td>\n<td>Psittacosis</td>\n</tr>\n<tr>\n<td>Leishman&ndash;Donovan bodies</td>\n<td>Kala-azar&nbsp;</td>\n</tr>\n<tr>\n<td>Negri bodies</td>\n<td>Rabies</td>\n</tr>\n<tr>\n<td>Guarnieri bodies</td>\n<td>Vaccinia</td>\n</tr>\n<tr>\n<td>Bollinger bodies</td>\n<td>Fowl pox</td>\n</tr>\n<tr>\n<td>Henderson&ndash;Paterson bodies</td>\n<td>Molluscum contagiosum&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-A bodies</td>\n<td>Yellow fever, Herpes virus infection&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-B bodies</td>\n<td>Adenovirus, poliovirus</td>\n</tr>\n<tr>\n<td>Rusell bodies</td>\n<td>Multiple myeloma&nbsp;</td>\n</tr>\n<tr>\n<td>Aschoff bodies</td>\n<td>Rheumatic fever&nbsp;</td>\n</tr>\n<tr>\n<td>Call&ndash;Exner bodies</td>\n<td>Granulosa cell tumor of the&nbsp;ovary&nbsp;</td>\n</tr>\n<tr>\n<td>Civatte (colloid) bodies</td>\n<td>Lichen planus&nbsp;</td>\n</tr>\n<tr>\n<td>Michaelis&ndash;Gutmann bodies</td>\n<td>Malakoplakia&nbsp;</td>\n</tr>\n<tr>\n<td>Lewy bodies</td>\n<td>Parkinson's disease&nbsp;</td>\n</tr>\n<tr>\n<td>Pappenheimer bodies</td>\n<td>Non-heme iron pigments in siderocytes&nbsp;</td>\n</tr>\n<tr>\n<td>Howell&ndash;Jolly bodies</td>\n<td>Splenectomy, Megaloblastic Anemia, Hemolytic anemia&nbsp;</td>\n</tr>\n<tr>\n<td>Heinz bodies</td>\n<td>G-6-PD deficiency&nbsp;</td>\n</tr>\n<tr>\n<td>Gamna&ndash;Gandy bodies</td>\n<td>Congestive splenomegaly&nbsp;</td>\n</tr>\n<tr>\n<td>Mallory bodies</td>\n<td>Hyaline inclusions in hepatocytes seen in alcoholic cirrhosis, Indian childhood cirrhosis</td>\n</tr>\n<tr>\n<td>Councilman bodies</td>\n<td>Hepatocytes undergoing apoptosis,&nbsp;seen mainly in acute viral hepatitis.</td>\n</tr>\n<tr>\n<td>Psammoma bodies</td>\n<td>Dystrophic calcification in meningioma, papillary serous cystadenoma of ovary &amp; papillary carcinoma of thyroid, papillary type of renal cell carcinoma.</td>\n</tr>\n<tr>\n<td>Donovan bodies</td>\n<td>Granuloma inguinale&nbsp;</td>\n</tr>\n<tr>\n<td>Nissl's bodies</td>\n<td>Cytoplasmic inclusions in neurons&nbsp;</td>\n</tr>\n<tr>\n<td>Mooser bodies</td>\n<td>Typhus fever</td>\n</tr>\n<tr>\n<td>Creola bodies</td>\n<td>Asthma&nbsp;</td>\n</tr>\n<tr>\n<td>Verocay bodies</td>\n<td>Schwannoma&nbsp;</td>\n</tr>\n<tr>\n<td>Schiller&ndash;Duval bodies</td>\n<td>Endodermal sinus tumor&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Hirano bodies</p>\n</td>\n<td>&nbsp;Alzheimer&rsquo;s disease</td>\n</tr>\n<tr>\n<td>\n<p>Ferruginous bodies</p>\n</td>\n<td>Asbestosis&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b9f5349aac904f03b790e0a2ad3fc27f.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5278",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following measures are associated with an increased life span?",
      "choices": [
        {
          "id": 1,
          "text": "Moderate or regular exercise for 30 min"
        },
        {
          "id": 2,
          "text": "Decrease stress"
        },
        {
          "id": 3,
          "text": "Decreasing calorie intake by 30 percent"
        },
        {
          "id": 4,
          "text": "Pharmacological intervention with proton pump inhibitors"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Decreasing calorie intake</strong> by 30&nbsp;percent&nbsp;will <strong>increase lifespan.</strong></p>\n<p><strong>Caloric restriction reduces</strong> both the degree of <strong>oxidative damage</strong> and the associated decline in function. It decreases the steady-state concentrations of products of oxidative damage to proteins, DNA, and lipids. This is due to <strong>decreased production</strong> of mitochondrial <strong>superoxide</strong> anion and hydrogen peroxide and increased antioxidant production. Overall, caloric restriction <strong>depresses the rate of energy metabolism.</strong></p>\n<div class=\"page\" title=\"Page 80\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Caloric restriction increases longevity both by <strong>reducing</strong> the <strong>signaling</strong> intensity of the insulin-like growth factor (<strong>IGF-1</strong>) pathway and by <strong>increasing sirtuins </strong>(NAD-dependent protein deacetylases).</p>\n<p>The <strong>attenuation</strong> of <strong>IGF-1</strong> signaling leads to <strong>lower rates</strong> of cell growth and <strong>metabolism</strong> that reduces cellular damage. A similar effect is produced&nbsp;by <strong>rapamycin.</strong> An <strong>increase</strong> in <strong>sirtuins</strong>&nbsp;(particularly sirtuin-6) <strong>promotes</strong> the <strong>expression</strong> of several <strong>genes</strong> whose products increase longevity&nbsp;by activating <strong>DNA repair</strong> enzymes through deacylation.</p>\n</div>\n</div>\n</div>\n</div>\n<p>Caloric restriction delays the onset of age-associated diseases such as cancer (including lymphomas and breast and prostate cancers), nephropathy, and cataracts. The onset of <strong>diabetes, hypertension, hyperlipidemia,</strong> and&nbsp;the development of autoimmune diseases is also decreased by caloric restriction.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5342",
      "difficulty": "medium"
    },
    {
      "text": "A 56-year-old man was diagnosed with COVID-19 and was put on mechanical ventilation. He passed away after a week. What is the likely post-mortem change seen in the lungs?",
      "choices": [
        {
          "id": 1,
          "text": "Thick layer of fibrin lining the alveoli"
        },
        {
          "id": 2,
          "text": "Acute and chronic alveolar hemorrhage"
        },
        {
          "id": 3,
          "text": "Perivascular cuffing"
        },
        {
          "id": 4,
          "text": "Pulmonary artery hypertrophy with increased resistance"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical scenario of a patient with <strong>COVID-19 pneumonia</strong> on <strong>mechanical ventilation</strong> is suggestive of <strong>acute respiratory distress syndrome</strong> (ARDS). A thick <strong>layer of fibrin </strong>or<strong> waxy hyaline membranes</strong> lining the alveolar walls are characteristic of ARDS.</p>\n<p><strong>COVID-19</strong> is a respiratory disease caused by <strong>SARS-CoV-2</strong>. These are <strong>enveloped positive-sense RNA viruses</strong>. The spread of SARS-CoV-2 is believed to be primarily via respiratory droplets,&nbsp;direct contact, airborne, and fomites.</p>\n<p>The major complication in patients with severe COVID-19 is <strong>ARDS</strong> requiring oxygen therapy and <strong>mechanical ventilation</strong>. ARDS is a clinical syndrome characterized by <strong>acute onset, severe dyspnea, tachypnea, hypoxemia</strong>, and <strong>pulmonary</strong> <strong>infiltrates</strong> leading to respiratory failure.</p>\n<p>Etiological factors can be divided into direct and indirect causes of lung injury as follows:</p>\n<table>\n<tbody>\n<tr>\n<td>Direct lung injury</td>\n<td>Indirect lung injury</td>\n</tr>\n<tr>\n<td><strong>Pneumonia</strong></td>\n<td><strong>Sepsis</strong></td>\n</tr>\n<tr>\n<td>Aspiration of gastric contents</td>\n<td><strong>Transfusions</strong></td>\n</tr>\n<tr>\n<td><strong>Near drowning</strong></td>\n<td>Drug overdose</td>\n</tr>\n<tr>\n<td>Toxic inhalational injury</td>\n<td>Multiple transfusions</td>\n</tr>\n<tr>\n<td>Pulmonary contusion</td>\n<td><strong>Pancreatitis</strong></td>\n</tr>\n<tr>\n<td><strong>COVID-19</strong></td>\n<td>Severe trauma like <strong>burns</strong>, flail chest, head trauma, multiple bone fractures</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Damage to the endothelial</strong> and alveolar epithelial cells, with inflammation, is the&nbsp;<strong>key initiating event</strong>&nbsp;and the basis of lung damage. Neutrophils&nbsp;play a significant role in tissue injury in this condition.</p>\n<p>There are <strong>three</strong> <strong>stages</strong> in the development of ARDS:</p>\n<ol>\n<li aria-level=\"1\"><strong>Exudative</strong> phase-&nbsp;occurs for the first <strong>7 days</strong> of the illness. This is associated with damage to alveolar-capillary endothelial cells and <strong>type I pneumocytes.&nbsp;</strong>This results in a breach in the tight alveolar barrier. The release of proinflammatory cytokines leads to the recruitment of <strong>neutrophils</strong> and the development of a <strong>hyaline</strong> <strong>membrane</strong> in the alveoli.</li>\n<li aria-level=\"1\"><strong>Proliferative</strong> phase-&nbsp;occurs from day <strong>7-21.</strong> <strong>Recovery</strong> from mechanical ventilation is seen in most patients.</li>\n<li aria-level=\"1\"><strong>Fibrotic</strong> phase<strong>-</strong>&nbsp;is associated with increased <strong>mortality</strong>. Extensive <strong>alveolar duct </strong>and<strong> interstitial fibrosis</strong> are seen.</li>\n</ol>\n<p><span data-preserver-spaces=\"true\">The image given below shows hyaline membrane formation in the alveolar walls seen in ARDS.</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a533955729c34508933fd3c8c697446bx1280x853.JPEG\" alt=\"Explanation Image\"><p>The chest X-ray features in ARDS usually develop <strong>12-24 hour</strong>s after initial lung insult as a result of proteinaceous interstitial edema. Within one week, a hyaline membrane occurs due to type 1 pneumocyte damage. There are <strong>diffuse bilateral coalescent opacities </strong>consistent with pulmonary edema.&nbsp;</p>\n<p>The image given below shows chest x-ray findings seen in ARDS.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c6fcbb117b59408d8b1994bb525822e6x751x600.PNG\" alt=\"Explanation Image\"><p><strong>Berlin's definition of ARDS</strong> predicts increased <strong>mortality</strong>. It considers the following parameters:</p>\n<ol>\n<li>Chest <strong>X-ray</strong> showing bilateral <strong>opacities</strong></li>\n<li><strong>Respiratory failure</strong> within<strong> 1 week</strong> of alveolar insult</li>\n<li><strong>Decreased PaO2/FiO2</strong> ratio to less than 300</li>\n<li>Symptoms of respiratory failure are not due to heart failure/fluid overload</li>\n</ol>\n<p>Diagnosis of COVID-19 is done by <strong>nucleic acid amplification testing</strong> of respiratory tract secretions by nasopharyngeal swab. It is associated with elevated inflammatory markers, such as <strong>interleukin 6</strong> (IL-6), tumor necrosis factor, <strong>ferritin</strong>, <strong>C-reactive protein</strong>, <strong>lactate dehydrogenase,</strong> and <strong>D-dimer</strong>.</p>\n<p><strong>Chest CT</strong> may be more sensitive than radiographs, but CT should be used principally for medical management of respiratory disease, not as a primary diagnostic tool for COVID-19.</p>\n<p>The image given below shows the management of COVID-19 infection.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d0e0cc5b928a43b4b8c344ce6c509bdcx1280x3722.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5345",
      "difficulty": "easy"
    },
    {
      "text": "A female patient presented with fatigue. Routine complete blood count analysis showed hemoglobin of 9 g/dL, MCV 60fL, and RBC count of 5.2 million. A peripheral smear showed microcytic hypochromic anemia. Which of the following is the next best investigation for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Serum ferritin levels"
        },
        {
          "id": 2,
          "text": "HbA2 levels"
        },
        {
          "id": 3,
          "text": "Serum folate levels"
        },
        {
          "id": 4,
          "text": "Serum homocysteine levels"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The next best investigation for this patient would be determining the&nbsp;<strong data-stringify-type=\"bold\">HbA2 levels</strong>, as the history of reduced hemoglobin, reduced MCV (<strong data-stringify-type=\"bold\">microcytic</strong>&nbsp;anemia) and&nbsp;<strong data-stringify-type=\"bold\">normal to high RBC count</strong>&nbsp;is suggestive of thalassemia.</p>\n<p>The MCV count divided by the RBC count is called the <strong>Mentzer index</strong>, which is lower than 13 in thalassemia due to the normal to high RBC count in the denominator. In iron deficiency anemia, it is higher than 13 as the MCV and the RBC count both are reduced.</p>\n<p><strong>Alpha-</strong> and<strong> beta-thalassemia</strong> are inherited disorders in which there is reduced production of alpha-globin or beta-globin chains, respectively. This leads to precipitation of the excess (unpaired) chains, interfering with red blood cell (RBC) production and survival.</p>\n<p>Clinical features in thalassemia include anemia, jaundice, skeletal deformities including facial deformities, changes in body habitus, growth impairment, and hepatosplenomegaly. Due to frequent blood transfusions, iron overload is also seen.&nbsp;</p>\n<p>Peripheral smear is likely to show&nbsp;<strong>microcytic hypochromic</strong> anemia with&nbsp;<strong>target</strong>&nbsp;cells,&nbsp;<strong>teardrop</strong>&nbsp;cells, and some&nbsp;<strong>coarse basophilic stippling</strong>&nbsp;in certain cases.</p>\n<p>The image given below shows peripheral smear findings in thalassemia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5e0a2458a25b487cb5085cc7db376be9x720x546.PNG\" alt=\"Explanation Image\"><p>An <strong>X-ray</strong> of the <strong>skull</strong> shows a <strong>crewcut appearance</strong> due to <strong>expansion</strong> of hematopoetically active<strong> marrow.</strong></p>\n<p>Thalassemia is usually <strong>managed</strong> by blood <strong>transfusions</strong> every 2-4 weeks and <strong>chelation therapy</strong> with <strong>deferoxamine, deferasirox, </strong>and<strong> deferiprone</strong> for <strong>iron</strong> chelation. <strong>Splenectomy</strong> is indicated when the transfusion requirement to maintain ideal hemoglobin increases. Hematopoietic stem cell transplantation <strong>(HSCT)</strong> is the <strong>only</strong> known <strong>curative</strong> treatment for thalassemia.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Serum ferritin level</strong> is used to diagnose iron-deficiency anemia <strong>(IDA).</strong> They are usually low in IDA.</p>\n<p>Option C: <strong>Serum folate level</strong> is used to diagnose <strong>macrocytic anemia</strong> due to a <strong>deficiency</strong> of <strong>folic</strong> acid.</p>\n<p>Option D: <strong>Serum homocysteine</strong> levels are increased in <strong>vitamin B12&ndash;deficient</strong> <strong>macrocytic</strong> anemia.</p><hr><h3>Related Pearl: Differential Diagnosis of Microcytic Anaemia</h3><table>\n<tbody>\n<tr>\n<td>Investigation</td>\n<td><strong>Iron- Deficiency Anemia</strong></td>\n<td><strong>Alpha or beta thalassemia</strong></td>\n<td><strong>Anemia of Chronic Disease</strong></td>\n</tr>\n<tr>\n<td><strong>Serum Iron</strong></td>\n<td>&lt;60 &micro;g/dL</td>\n<td>Normal/Increased</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Serum Ferritin</strong></td>\n<td>&lt;20 &micro;g/L</td>\n<td>Normal/Increased</td>\n<td>Increased</td>\n</tr>\n<tr>\n<td><strong>TIBC</strong></td>\n<td>Increased</td>\n<td>Normal</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Transferrin saturation</strong></td>\n<td>&lt;15%</td>\n<td>Normal</td>\n<td>Normal/Decreased</td>\n</tr>\n<tr>\n<td><strong>MCV</strong></td>\n<td>Decreased</td>\n<td>&nbsp;Decreased</td>\n<td>Normal/Decreased</td>\n</tr>\n<tr>\n<td><strong>RBC count</strong></td>\n<td>Decreased</td>\n<td>Normal/Increased</td>\n<td>Normal/Increased</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>TIBC: Total iron-binding capacity&nbsp;</p><hr><h3>Related Pearl: Thalassemia syndromes</h3><p>Normally each individual carries 4 functional alpha chain genes and 2 functional beta chain genes. Alpha and beta-thalassemia are inherited disorders in which there is reduced production of alpha-globin or beta-globin chains, respectively.</p>\n<ul>\n<li data-canvas-width=\"535.628896311106\"><strong>Alpha thalassemia:</strong> Gene deletion is the most common cause of reduced α-chain synthesis.</li>\n<li data-canvas-width=\"535.628896311106\"><strong>Beta +- thalassemia:</strong> The most common cause is splicing mutation.</li>\n<li data-canvas-width=\"535.628896311106\"><strong>Beta 0- thalassemia:</strong> Chain terminator mutations are the most common cause.</li>\n</ul>\n<p>The table below describes the features of typical thalassemia syndromes:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Alpha thalassemias</strong></td>\n<td><strong> Hb Barts</strong></td>\n<td><strong>HbH disease </strong></td>\n<td><strong>Minor</strong></td>\n<td><strong>Silent carrier</strong></td>\n</tr>\n<tr>\n<td><strong>Genotype</strong></td>\n<td>(- - / - - )</td>\n<td>\n<p>(α -/ - -)</p>\n<p>or</p>\n<p>(α<span>*</span> -/ - -)</p>\n</td>\n<td>\n<p>(α -/α -)</p>\n<p>or</p>\n<p>(α α/- -)</p>\n</td>\n<td>(α α/α -)</td>\n</tr>\n<tr>\n<td><strong>Laboratory findings</strong></td>\n<td>Severe microcytic anemia with hydrops fetalis; fatal in utero</td>\n<td>Moderate microcytic anemia</td>\n<td>Mild microcytic anemia</td>\n<td>Normal hemoglobin, normal MCV</td>\n</tr>\n<tr>\n<td><strong>Hemoglobin electro-phoresis</strong></td>\n<td>Hb Barts (γ globin tetramers); Hb Portland (embryonic hemoglobin); no HbF, HbA, or HbA<sub>2</sub></td>\n<td>HbH (beta-globin tetramers -up to 30%); HbA<sub>2 </sub>(up to 4%)</td>\n<td>Hb Barts (3 to 8%)</td>\n<td>Normal</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>\"-\" denotes deletion of an alpha gene and \"α\" denotes normal alpha gene and \"α* \" refers to a mutant alpha chain gene.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Beta thalassemias</strong></td>\n<td><strong>Major (transfusion-dependent)</strong></td>\n<td><strong>Intermedia (non-transfusion-dependent)</strong></td>\n<td><strong>Minor (also called trait or carrier)</strong></td>\n</tr>\n<tr>\n<td><strong>Genotype</strong></td>\n<td>\n<p>Homozygous</p>\n<p>β<sup>0</sup>/β<sup>0</sup></p>\n<p>or</p>\n<p>β<sup>0</sup>/β<sup>+</sup></p>\n<p>or</p>\n<p>β+/β+ </p>\n</td>\n<td>\n<p>Variable</p>\n<p>β0/β+</p>\n<p>or</p>\n<p>β<sup>+</sup>/β<sup>+</sup></p>\n<p>or</p>\n<p>β0/β</p>\n<p>or</p>\n<p>β+/β</p>\n</td>\n<td>\n<p>Heterozygous</p>\n<p>β<sup>0</sup>/β</p>\n<p>or</p>\n<p>β<sup>+</sup>/β</p>\n</td>\n</tr>\n<tr>\n<td><strong>Laboratory findings</strong></td>\n<td>Severe microcytic anemia with target cells (typical Hb 3 to 4 g/dL)</td>\n<td>Moderate microcytic anemia</td>\n<td>Mild microcytic anemia</td>\n</tr>\n<tr>\n<td><strong>Hemoglobin electrophoresis</strong></td>\n<td>HbA<sub>2 </sub>(5% or more); HbF (up to 95%); no HbA</td>\n<td>HbA<sub>2</sub> (4% or more); HbF (up to 50%)</td>\n<td>HbA<sub>2</sub> (4% or more); HbF (up to 5%)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>β<sup>0</sup> refers to no beta-globin production; β<sup>+</sup> refers to decreased beta-globin production.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5346",
      "difficulty": "hard"
    },
    {
      "text": "A 56-year-old man presents with dragging pain in the abdomen. On examination, there is massive splenomegaly. Peripheral smear shows leukocytosis with increased myelocytes, metamyelocytes and basophils. Which of the following translocation is seen in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "t(9;22)"
        },
        {
          "id": 2,
          "text": "t(8;22)"
        },
        {
          "id": 3,
          "text": "t(15;17)"
        },
        {
          "id": 4,
          "text": "t(8;14)"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical scenario of massive <strong>splenomegaly</strong> and peripheral smear shows <strong>leukocytosis</strong> with <strong>increased myelocytes, metamyelocytes </strong>and<strong> basophils</strong> are suggestive of <strong>chronic myeloid leukemia </strong>(CML).&nbsp;A<strong> translocation</strong> between<strong> t(9;22)</strong> is seen in this condition.&nbsp;</p>\n<p>CML is a myeloproliferative neoplasm. It is caused due to <strong>BCR </strong>(on chromosome 22) <strong>- ABL </strong>(on chromosome 9)<strong> fusion gene&nbsp;translocation mutation. </strong>It results in the formation of the<strong> Philadelphia chromosome </strong>which is of CML.<strong><br /></strong></p>\n<p>The image given below shows <strong>Philadelphia chromosome</strong> showing <strong>reciprocal (9;22)(q34;q11) translocation</strong> seen in CML.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b96832451c214c58997e68b908032784x720x793.PNG\" alt=\"Explanation Image\"><p>The resulting BCR-ABL translocation results in the activation of <strong>tyrosine kinase</strong> that signals pro-growth and pro-survival pathways like <strong>RAS</strong> and <strong>JAK/STAT</strong> pathways resulting in the proliferation of hematopoietic stem cells.</p>\n<p>Patients typically present with a dragging sensation abdomen due to <strong>splenomegaly</strong> or splenic infarct, fatigue, malaise, and weight loss.</p>\n<p>On peripheral smear there is <strong>l</strong><strong>eukocytosis&nbsp;</strong>with leukocyte count,<strong>&nbsp;</strong>often exceeding<strong> 100,000 cells/mm<sup>3 </sup></strong>(neutrophils, band forms, metamyelocytes, myelocytes, eosinophils, and basophils), <strong>b</strong><strong>lasts </strong>are usually<strong> less than 10% </strong>of the circulating cells, the platelet count is usually increased.</p>\n<p>The image below shows peripheral smear findings of chronic myeloid leukemia (CML) with neutrophils, myelocytes, metamyelocytes, and band cells.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0bfb24b654f84beea97ba959e042ab62x1280x960.JPEG\" alt=\"Explanation Image\"><p>Bone marrow is <strong>h</strong><strong>ypercellular </strong>due to increased numbers of <strong>maturing granulocytic precursors</strong>&nbsp;with <strong>s</strong><strong>ea-blue histiocytes</strong> (macrophages with wrinkled, green-blue cytoplasm).</p>\n<p>Fluorescence in situ hybridization&nbsp;<strong>(FISH)</strong> or polymerase chain reaction(<strong>PCR</strong>) to detect the <strong>BCR-ABL gene.&nbsp;</strong>Leucocyte alkaline phosphatase (<strong>LAP</strong>) <strong>score</strong> is <strong>decreased</strong> in cases of CML.</p>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p><strong>Sokal scoring&nbsp;</strong>is used in assessing the <strong>prognosis</strong> of this patient. The prognosis of <strong>CML</strong> can be assessed based on:</p>\n<ul>\n<li>Age</li>\n<li>Spleen size</li>\n<li>Platelet count</li>\n<li>Percentage of blast cells in the blood</li>\n</ul>\n<p>FDA-approved <strong>tyrosine kinase inhibitors</strong> for the treatment of CML are <strong>imatinib</strong>, nilotinib, dasatinib, bosutinib, and ponatinib.</p>\n</div>\n</div>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>&nbsp;Complications, if left untreated:</p>\n<ul>\n<li><strong>Accelerated phase</strong>- increased anemia, thrombocytopenia, and basophilia</li>\n<li>A<strong> blast crisis</strong>- may transform into acute leukemia (AML/ALL)</li>\n</ul>\n<p>Other options:</p>\n<p>Options B and D: <strong>t(8;14)</strong> and<strong> t(8;22)</strong> are seen in <strong>Burkitt lymphoma</strong>. It is associated with increased <strong>MYC</strong> levels. All endemic cases of Burkitt lymphoma are caused by the <strong>Ebstein-Barr virus</strong>. Microscopy shows a characteristic <strong>starry sky pattern</strong>.</p>\n<p>The image given below shows a starry sky pattern seen in Burkitt lymphoma.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9e4bccafcf0c4d04b94530b1898ed297x1024x768.JPEG\" alt=\"Explanation Image\"><p>Option C: <strong>t(15;17) </strong>is seen in <strong>acute promyelocytic leukemia</strong>. It is characterized by promyelocytes with <strong>Auer rods</strong> on bone marrow aspirate. <strong>All-trans-retinoic acid</strong> is used for the treatment.</p>\n<p>The image given below shows bone marrow findings in acute promyelocytic leukemia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fb332e3900cd482daf7af714c0b6b259x508x533.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Malignancies, Translocations and Affected Genes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Malignancy </strong></p>\n</td>\n<td>\n<p><strong>Translocation</strong></p>\n</td>\n<td>\n<p><strong>Affected Genes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CLL/ Small lymphocytic lymphoma</p>\n</td>\n<td>\n<p>t(14;19)</p>\n</td>\n<td>\n<p><em>-</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic myelogenous leukemia (CML)</p>\n</td>\n<td>\n<p>t(9;22)</p>\n</td>\n<td>\n<p><em>ABL </em>9q34</p>\n<p><em>BCR </em>22q11</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute myeloid leukemia (AML)</p>\n</td>\n<td>\n<p>t(8; 21), t(15; 17)</p>\n</td>\n<td>\n<p><em>AML1 21</em>q22</p>\n<p><em>ETO 8</em>q22</p>\n<p><em>PML </em>15q22</p>\n<p><em>RARA </em>17q21</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Precursor B cell ALL</p>\n</td>\n<td>\n<p>t(9;22), t(4;11)</p>\n</td>\n<td>&nbsp;\n<p>BCR/ABL</p>\n<p>AF4, ALLI</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>t(8; 14), t(2;8) t(8;22)</p>\n</td>\n<td>\n<p><em>c-myc&nbsp;</em>8q24</p>\n<p><em>IGH </em>14q32</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mantle cell lymphoma</p>\n</td>\n<td>\n<p>t(11; 14)</p>\n</td>\n<td>\n<p><em>CCND1 </em>11q13</p>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL1</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Follicular lymphoma</p>\n</td>\n<td>\n<p>t(14; 18)</p>\n</td>\n<td>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL2 </em>18q21</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ewing sarcoma</p>\n</td>\n<td>\n<p>t(11; 22)</p>\n</td>\n<td>\n<p><em>FLI1 </em>11q24</p>\n<p><em>EWSR1 </em>22q12</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic adenocarcinoma</p>\n</td>\n<td>\n<p>t(7; 21), t(17; 21)</p>\n</td>\n<td>\n<p><em>TMPRSS2 </em>(21q22.3)</p>\n<p><em>ETV1</em> (7p21.2)</p>\n<p><em>ETV4 </em>(17q21)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse large B-cell lymphoma</p>\n</td>\n<td>&nbsp;t(14;18)</td>\n<td>&nbsp;\n<p><em>BCL-6</em>,&nbsp;p53</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>MALT lymphoma</p>\n</td>\n<td>t(11;18)</td>\n<td><em>API2/MALT</em>, <em>BCL-10</em></td>\n</tr>\n<tr>\n<td>\n<p>CD30+ Anaplastic large cell lymphoma</p>\n</td>\n<td>t(2;5)</td>\n<td><em>ALK</em></td>\n</tr>\n<tr>\n<td>\n<p>Lymphoplasmacytoid lymphoma</p>\n</td>\n<td>t(9;14)</td>\n<td><em>PAX5, IGH</em></td>\n</tr>\n<tr>\n<td>\n<p>Synovial sarcoma</p>\n</td>\n<td>t(X;18)(p11;q11)&nbsp;</td>\n<td>&nbsp;\n<p><em>SS18-SSX2</em></p>\n<p><em>SS18-SSX4</em></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Alveolar soft-part sarcoma</td>\n<td>&nbsp;t(X;17)(p11.2;q25)</td>\n<td>&nbsp;<em>TFE3-ASPL</em></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Origin of leukemia / lymphoma and their immunophenotypes</h3><table>\n<tbody>\n<tr>\n<td><strong>B cell precursors</strong></td>\n<td><strong>Derived lymphomas/leukemia</strong></td>\n<td><strong>Immunophenotype</strong></td>\n</tr>\n<tr>\n<td>Pro-B cell</td>\n<td>Pro-B cell ALL</td>\n<td>CD34,&nbsp;CD19, CD79a</td>\n</tr>\n<tr>\n<td>Pre-B cell</td>\n<td>Pre-B cell ALL</td>\n<td>CD19, CD79a,&nbsp;CD10, Tdt</td>\n</tr>\n<tr>\n<td>Mature B cell</td>\n<td>CLL/SLL</td>\n<td>\n<p>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD 23, CD5</p>\n</td>\n</tr>\n<tr>\n<td>Mantle zone</td>\n<td>Mantle zone lymphoma</td>\n<td>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD5</td>\n</tr>\n<tr>\n<td>Germinal center/Follicular center</td>\n<td>\n<p>Follicular lymphoma</p>\n<p>&nbsp;</p>\n<p>Diffuse large B-cell lymphoma</p>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>CD 79a, CD 19, CD20, CD21,CD22, CD10, CD 23, Bcl-2</p>\n<p>CD10, Cd23, Bcl-6</p>\n<p>CD19, CD20, CD22, CD79a, CD10, Bcl-6</p>\n</td>\n</tr>\n<tr>\n<td>Memory B cells</td>\n<td>Extranodal marginal zone lymphoma</td>\n<td>CD19, CD79a,CD 20, surface Ig</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>CLL:&nbsp;Chronic lymphocytic leukemia&nbsp;</p>\n<p>SLL:&nbsp;Small lymphocytic lymphoma</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5326",
      "difficulty": "easy"
    }
  ]
}